The emerging treatment of this peptide represents a significant development in the handling of the condition. Different to existing medications, tirzepatide targets dual pathways – GLP-1 and the GIP hormone – https://tirzepatidepeptide104334.wizzardsblog.com/41999925/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment